Quick Takeaways
- 111 Equity Group filed SCHEDULE 13D/A for Matinas Biopharma Holdings, Inc. Common Stock (MTNB).
- Disclosed ownership: 3.6%.
- Date of event: 13 Feb 2025.
111 Equity Group - 13 Feb 2025 SCHEDULE 13D/A Report for Matinas Biopharma Holdings, Inc. Common Stock (MTNB)
- Filing Manager
- 111 Equity Group
- Reporting Manager
- 111 Equity Group LLC
- Symbol
- MTNB
- Shares outstanding
- 5,086,953 shares
- Disclosed Ownership
- 183,639 shares
- Ownership
- 3.6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 Feb 2025, 14:22:47 UTC
- Date of event
- 13 Feb 2025
- Previous filing
- 06 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"111 Equity Group disclosed 3.6% ownership in Matinas Biopharma Holdings, Inc. Common Stock (MTNB) on 13 Feb 2025."
What Changed
- Previous schedule filing date: 06 Jan 2025.
- Current filing was accepted on 19 Feb 2025, 14:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Chaim Herzog | 3.6% | 183,639 | 0 | 183,639 | /s/ Chaim Herzog | Chaim Herzog | |
| 111 Equity Group LLC | 3.6% | 183,639 | 0 | 183,639 | /s/ Chaim Herzog | Chaim Herzog, Manager | 0002024448 |